These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36859833)

  • 1. Erythropoietin promotes myocardial infarction repair in mice by improving the function of Sca-1
    Zuo L; Li DD; Ma XX; Shi SH; Lyu DC; Shen J; Zhang WF; Gao EH; Cao JM
    Sheng Li Xue Bao; 2023 Feb; 75(1):36-48. PubMed ID: 36859833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.
    Prunier F; Pfister O; Hadri L; Liang L; Del Monte F; Liao R; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H522-9. PubMed ID: 16997893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model.
    Zhang Y; Zhu D; Wei Y; Wu Y; Cui W; Liuqin L; Fan G; Yang Q; Wang Z; Xu Z; Kong D; Zeng L; Zhao Q
    Acta Biomater; 2019 Mar; 86():223-234. PubMed ID: 30660010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.
    Stein A; Knödler M; Makowski M; Kühnel S; Nekolla S; Keithahn A; Weidl E; Groha P; Schürmann M; Saraste A; Botnar R; Oostendorp RA; Ott I
    BMC Cardiovasc Disord; 2010 Sep; 10():43. PubMed ID: 20849606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
    Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
    FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits.
    Yamada Y; Kobayashi H; Iwasa M; Sumi S; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Kiso M; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1124-33. PubMed ID: 23417861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.
    Klopsch C; Skorska A; Ludwig M; Lemcke H; Maass G; Gaebel R; Beyer M; Lux C; Toelk A; Müller K; Maschmeier C; Rohde S; Mela P; Müller-Hilke B; Jockenhoevel S; Vollmar B; Jaster R; David R; Steinhoff G
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.
    Wang X; Hu Q; Nakamura Y; Lee J; Zhang G; From AH; Zhang J
    Stem Cells; 2006 Jul; 24(7):1779-88. PubMed ID: 16614004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
    Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
    Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
    Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.
    Kanashiro-Takeuchi RM; Takeuchi LM; Hatzistergos K; Quevedo H; Selem SM; Treuer AV; Premer C; Balkan W; Margitich I; Song Y; Hu Q; Hare JM
    Clin Transl Sci; 2011 Jun; 4(3):168-74. PubMed ID: 21707946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat.
    Hale SL; Sesti C; Kloner RA
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):211-5. PubMed ID: 16044033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
    Klopsch C; Furlani D; Gäbel R; Li W; Pittermann E; Ugurlucan M; Kundt G; Zingler C; Titze U; Wang W; Ong LL; Wagner K; Li RK; Ma N; Steinhoff G
    J Cell Mol Med; 2009 Apr; 13(4):664-79. PubMed ID: 19449462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
    J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
    Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
    Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
    Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.